Manufacturer
65 recalls in our database name Health Innovations Pharmacy, Inc as the manufacturing or recalling firm.
Of the 65 recalls from Health Innovations Pharmacy, Inc we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 33 (51%) are Severe.
The manufacturer string comes from the agency’s own source notice — for FDA recalls, the “recalling firm” field; for NHTSA recalls, the vehicle manufacturer; for CPSC recalls, the firm-of-record on the joint press release. A single corporate family can appear under multiple manufacturer strings as agency notices aren’t standardized on a canonical name. If you don’t see recalls you expect, try a parent-company search or a broader full-text search.
Severity scores below are computed from the agency’s classification and the recall text, never from manufacturer behaviour or history. Many manufacturers issue routine corrective actions (software updates, labelling corrections) that are correctly scored low — having recalls on this list isn’t inherently a quality signal.
Health Innovations Pharmacy is recalling Glycerin 98.5% Opth. Solution because inspection observations indicate a lack of assurance regarding sterility and stability data.
Health Innovations Pharmacy is recalling Verapamil HCl 15% Topical Cream due to lack of assurance of sterility and stability data.
Health Innovations Pharmacy is recalling Cyanocobalamin 2000mcg/1ml Injection due to inspection findings regarding sterility and stability data.
Health Innovations Pharmacy is recalling Azithromycin 100 mg Rectal Suppositories because inspection findings indicate a lack of assurance regarding sterility and stability data.
Health Innovations Pharmacy is recalling Sildenafil 10 mg/1 mL Suspension because inspection observations indicate a lack of assurance regarding sterility and stability data.
Health Innovations Pharmacy is recalling all lots of Lansoprazole 3 mg/mL Suspension due to quality control issues affecting sterility and stability.
Health Innovations Pharmacy is recalling Boric Acid Vaginal Capsules due to quality control issues affecting sterility and stability data.
Health Innovations Pharmacy is recalling Nystatin 50,000 Units Suppositories due to quality control issues affecting sterility and stability.
Health Innovations Pharmacy is recalling Levodopa 250 mg NSR Capsules due to quality control issues affecting sterility and stability data.
Health Innovations Pharmacy is recalling Hydroxyurea 100 mg/1 mL Suspension because inspection findings indicate a lack of assurance regarding sterility and stability data.
Health Innovations Pharmacy is recalling Phenylephrine 0.5% Solution due to quality control issues that present a risk to sterility and stability.
Health Innovations Pharmacy is recalling DHEA 10 mg SR Capsules because inspection findings indicate a lack of assurance regarding sterility and stability data.
Health Innovations Pharmacy is recalling Colchicine 0.6 mg capsules because inspection observations indicate a lack of assurance regarding sterility and stability data.
Health Innovations Pharmacy is recalling Nifedipine 0.2% - Lidocaine 2% Jelly due to sterility and stability concerns. The recall covers all lots distributed in North Carolina.
Health Innovations Pharmacy is recalling Carvedilol 1.25 mg/mL due to quality control issues affecting sterility and stability data.